References
- Castle DJ, Ames FR. Cannabis and the brain. Australian and New Zealand Journal of Psychiatry 1996; 30: 179–183
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders., 4th ed. American Psychiatric Association, Washington, DC 1994
- Glass DS, Bowers MB, Jr. Chronic psychosis associated with long-term psychotomimetic drug use. Archives of General Psychiatry 1970; 23: 997–1003
- Bowers MB, Jr. The role of drugs in the production of schizophreniform psychoses and related disorders. Psychopharmacology: a generation of progress, MA Lipton, A DiMascio, KF Killem. Raven, New York 1978; 819–823
- Boutros NN, Bowers MB, Jr. Chronic substance-induced psychotic disorders: the state of the literature. Journal of Neuropsychiatry and Clinical Neurosciences 1996; 8: 262
- Tunving K. Psychiatric effects of cannabis use. Acta Psychiatrica Scandinavica 1985; 72: 133–136
- Tennant FS, Groesbeck CJ. Psychiatric aspects of hashish. Archives of General Psychiatry 1972; 27: 133–136
- Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet 1987; ii: 1483–1486
- Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenia disorders. Archives of General Psychiatry 1994; 51: 273–279
- Allebeck P, Adamson C, Engstrom A. Cannabis and schizophrenia: a longitudinal study of cases treated in Stockholm County. Acta Psychiatrica Scandinavica 1993; 88: 21–24
- Andreasson S, Allebeck P, Ryberg U. Schizophrenia in users and non-users of cannabis: a longitudinal study in Stockholm County. Acta Psychiatrica Scandinavica 1989; 79: 505–510
- Breakey WR, Goodell H, Lorenz PC, et al. Hallucinogenic drugs as precipitants of schizophrenia. Psychological Medicine 1974; 4: 255–261
- Cleghorn JM, Kaplan RD, Szechman B, et al. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function. Journal of Clinical Psychiatry 1991; 52: 26–30
- Arndt S, Tyrrell G, Flaum M, et al. Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychological Medicine 1992; 22: 379–388
- Bowers MB, Jr, Mazure CM, Nelson JC, et al. Psychotogenic drug use and neuroleptic response. Schizophrenia Bulletin 1990; 16: 81–85
- Castle DJ, Ames FR. Cannabis and the brain. Australian and New Zealand Journal of Psychiatry 1996; 30: 179–183
- Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet 1987; ii: 1483–1485
- McGuire PK, Jones P, Harvey I, Williams M, McGuffin P, Murray RM. Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis. Schizophrenia Research 1995; 15: 277–281
- Patton G. An epidemiological case for separate adolescent psychiatry?. Australian and New Zealand Journal of Psychiatry 1996; 5: 563–566
- Stein C. Trends in adolescent psychopathology. Canadian Journal of Psychiatry 1982; 27: 301–306
- Mayer-Gross Slater Roth. Schizophrenia. Clinical psychiatry, 3rd ed., Roth Slater. Williams and Wilkins, Baltimore 1969; 237–238
- Watkins W. Affective disorders in childhood and adolescence. Affective disorders, PR Joyce, SE Romans, PM Ellis, TS Silverstone. University of Otago, New Zealand 1995; 215–239
- Engstrom M. Manic depressive illness in adolescence. Journal of the American Academy of Child and Adolescent Psychiatry 1978; 17: 514–525
- Flament M, Whitaker A, Rapoport J. Obsessive compulsive disorder in adolescence—an epidemiological study. Journal of the American Academy of Child and Adolescent Psychiatry 1988; 27: 764–771
- Burke D, Fanker S. Fluoxetine and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Australian and New Zealand Journal of Psychiatry 1996; 30: 295–298
- Moses AM, Streeten D HP. Disorders of the neurohypophysis. Harrison's principles of internal medicine, 3rd ed., KJ Isselbacher, E Braunwald, JD Wilson, JB Martin, AS Fauci, DL Kasper. McGraw-Hill, New York 1994; 1928–1930
- Abbott R. Hyponatraemia due to antidepressant medications. Annals of Emergency Medicine 1983; 12: 708–710
- Ayonrinde OT, Reutens SG, Sanfilippo FM. Paroxetine-induced SIADH [letter]. Medical Journal of Australia 1995; 163: 390
- Adverse Drug Reactions Advisory Committee. Talking about fluoxetine. Australian Adverse Drug Reaction Bulletin 1994; 13: 14
- Anonymous. Selective serotonin reuptake inhibitors and SIAD Adverse H. Drug Reactions Advisory Committee. Medical Journal of Australia 1996; 164: 562
- Jackson C, Carson W, Marowitz J, Mintzer J. SIADH associated with fluoxetine and sertraline therapy [letter]. American Journal of Psychiatry 1995; 152: 809–810
- Thornton SL, Resch DS. SIADH associated with sertraline therapy [letter]. American Journal of Psychiatry 1995; 152: 809
- Ball CJ, Herzberg JS. Hyponatraemia and selective serotonin reuptake inhibitors. International Journal of Geriatric Psychiatry 1994; 9: 819–822
- Blacksten JV, Birt JA. Syndrome of inappropriate secretion of antidiuretic hormone secondary to fluoxetine. Annals of Pharmacotherapy 1993; 27: 723–724
- Burke D, Fanker S. Fluoxetine and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Australian and New Zealand Journal of Psychiatry 1996; 30: 295–298
- Voegeli J, Baumann P. Inappropriate secretion of antidiuretic hormone and SSRIs [letter]. British Journal of Psychiatry 1996; 169: 524–525
- Fanker S, Burke D. Fluoxetine-induced SIADH: most likely in the elderly? [letter]. Australian and New Zealand Journal of Psychiatry 1996; 30: 299–301
- Adverse Drug Reactions Advisory Committee (ADRAC). Selective serotonin reuptake inhibitors and SIADH. Medical Journal of Australia 1996; 164: 562
- Tierney WM, Martin DK, Greenlee MC, Zerbe RL, McDonald CJ. The prognosis of hyponatraemia at hospital admission. Journal of General Internal Medicine 1986; 1: 380–385
- Rider JM, Mauger TF, Jameson JP, Notman DD. Water handling in patients receiving haloperidol decanoate. Annals of Pharmacotherapy 1995; 29: 663–666
- Wilton NM. The fishing news. Australian and New Zealand Journal of Psychiatry 1996; 30: 435–441
- Berk M, Terre-Blanche MJ, Maude C, Lucas MD, Mendelsohn M, O'Neill-Kerr AJ. Season of birth and schizophrenia: southern hemisphere data. Australian and New Zealand Journal of Psychiatry 1996; 30: 220–222
- Hare EH. Season of birth in schizophrenia and neurosis. American Journal of Psychiatry 1975; 132: 1168–1171
- Parker G, Balza B. Season of birth and schizophrenia—an equatorial study. Acta Psychiatrica Scandinavica 1977; 56: 143–146
- McGrath J, Welham J, Pemberton M. Month of birth, hemisphere of birth and schizophrenia. British Journal of Psychiatry 1995; 167: 783–785
- Krupinski J, Stoller A, King D. Season of birth in schizophrenia: an Australian study. Australian and New Zealand Journal of Psychiatry 1976; 10: 311–314